Question Bank › Named catch-up gap

Named catch-up gap

Named catch-up gap: management identifies where the company visibly lags peers or its own potential, and is already clos

Calls Tested
500
Answered YES
24
Hit Rate
4.8%
rare by design

MaxLinear, Inc. (MXL) — this company's answers

NO on the Q2 2017 call 2017-08-08 C+
The model's full reasoning — Q2 2017 call → NO我们根据转录内容判断。管理层是否明确指出公司当前在某个具体维度上表现不佳(相对于同行、行业规范或自身潜力),并描述已在进行的工作来缩小该差距,且管理层将其视为不依赖市场改善的改进来源。 浏览转录内容,管理层提到多个方面:例如,在运营杠杆方面,提到“aggressively manage toward a point of cost energies from our recent acquisitions”,但未指定具体差距。提到库存周转率下降(从4.9降到3.6),但未明确将其作为差距。提到“days sales outstanding”增加,但归因于收购。提到“legacy Entropic products”下降,但那是产品生命周期。 是否有管理层承认公司落后于自身潜在水平或同行?例如,在模拟卫星业务中,提到在直接TV账户中未能保持市场份额,但那是归因于竞争,而非内部差距。在光学部分,归因于市场疲软。在卫星业务,提到“lumpiness”,但未归因于内部低效。 关于库存周转率,管理层说“inventory turns metric is impacted by the Exar acquisition and their legacy distributor and discrete component intensity, which is the focus of ongoing integration efforts to better align with MaxLinear's target model of approximately 6 inventory turns.” 这里明确提到了一个目标(6 turns)和正在进行的整合工作(“ongoing integration efforts”),但未说明当前差距有多大(实际3.6 vs 6),但差距明显。管理层是否将其视为改进来源?他说“which is the focus of ongoing integration efforts”,表明工作已在进行,且目标明确。但这是否是“meaningful source of improvement”呢?他并未说这能带来多少收益,但确实承认了差距并正在解决。然而,这是否是“不依赖市场条件”的?整合工作是内部努力。 另外,关于毛利率,非GAAP毛利率61%,但未提到与同行比较。关于运营费用,提到“we continue to evaluate our staffing levels globally particularly following our recent acquisition activity to strike a balance between driving near-term operating leverage and staffing key long-term growth initiatives.” 但未具体指明差距。 可能最接近的是库存周转率。管理层明确说“target model of approximately 6 inventory turns”,当前3.6,差距明显,并且说“focus of ongoing integration efforts”,说明工作已在进行。但这是否是“meaningful source of improvement”?未提及收益大小,但至少是明确的差距和已进行的努力。 然而,问题要求“具体命名维度”和“解释机制”。这里维度是库存周转率,机制是整合Exar业务以改善库存管理。但管理层是否将其视为“meaningful source of improvement”?他似乎更关注运营杠杆,但未直接说这能带来多少改进。 还有关于“legacy analog channel stacking”的下降,但那是产品淘汰。 另一个点:管理层提到“we have begun deleveraging”但那是财务杠杆。 我认为答案可能是NO,因为没有明确说“我们落后于同行”或“我们自身潜力”,且未描述具体的关闭机制。虽然提到了目标,但未说明如何实现。 再仔细看:库存周转率目标6,当前3.6,差距明显,且“ongoing integration efforts”是已进行的。但管理层没有说这将是收入或利润的显著来源。可能不够具体。 另外,在运营费用方面,他提到“we continue to evaluate our staffing levels globally”但那是评估,不是已执行。 综合,我认为答案NO。因为虽然提到了库存周转率差距和目标,但未明确说这是“underperforms”或“closing gap”是改进来源,且机制未详细说明。但问题要求“管理层的自身诊断”,他确实承认了差距,但未描述具体行动细节。 再读:“Our inventory turns are 3.6... compared to 4.9 turns... and 5.6 turns...

← Back to the full MXL analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management IDENTIFY A SPECIFIC, NAMED DIMENSION ON WHICH THE COMPANY CURRENTLY UNDERPERFORMS — relative to industry peers, industry norms, or the company's own demonstrated potential elsewhere in its business — AND describe work ALREADY UNDERWAY to close that specific gap, with management treating the closing of it as a meaningful source of improvement that does not depend on market conditions getting better? Answer YES when management's own words convey, in whatever form fits the business, ONE coherent self-diagnosis with both halves present: (1) A NAMED GAP, OWNED BY MANAGEMENT: management itself states, concretely, where the company lags — for example margins, productivity, utilization, pricing, mix, service levels, penetration of its own customer base, or performance of one region, segment, or facility versus the company's own better ones or versus what peers demonstrably achieve — identified specifically enough that a reader knows exactly what is deficient and roughly how large the shortfall is; and (2) CLOSING WORK IN MOTION WITH THE MECHANISM EXPLAINED: management describes the concrete actions already executing to close it — not aspirations — and conveys why the gap is closable by the company's own effort (the better level is already achieved by peers or by the company's own best operations, so the target is demonstrated rather than theoretical), with early progress or a credible operational path visible in the current period. Answer NO if management only claims general improvement opportunity without naming a specific measurable gap. NO if the gap is blamed on external conditions that must improve. NO if the closing work is only planned, promised, or under study. NO if the gap-closing is ordinary cost-cutting rhetoric with no named benchmark. NO if the diagnosis appears only in an analyst's question that management does not itself adopt. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
ASO Academy Sports and Outdoors, Inc. Q1 2024 2024-06-11 C+
MEG Montrose Environmental Group, Inc. Q3 2023 2023-11-08 C+
RVLV Revolve Group, Inc. Q3 2023 2023-11-01 C
CMG Chipotle Mexican Grill, Inc. Q3 2023 2023-10-27 B+
SWK Stanley Black & Decker, Inc. Q1 2023 2023-05-04 D
TMCI Treace Medical Concepts, Inc. Q2 2022 2022-08-13 B+
STC Stewart Information Services Corporation Q1 2022 2022-04-29 C+
KD Kyndryl Holdings, Inc. Q4 2021 2022-03-01 C+
FLUX Flux Power Holdings, Inc. Q2 2022 2022-02-10 D
HNRG Hallador Energy Company Q3 2021 2021-11-09 C+
LPTH LightPath Technologies, Inc. Q4 2021 2021-09-09 D
KOP Koppers Holdings Inc. Q2 2018 2018-08-12 C+
MKC McCormick & Company, Incorporated Q2 2018 2018-06-28 C+
ACHC Acadia Healthcare Company, Inc. Q4 2017 2018-02-22 C+
ADNT Adient plc Q1 2018 2018-01-29 D
HOLX Hologic, Inc. Q4 2017 2017-11-08 D
STKL SunOpta Inc. Q2 2017 2017-08-09 C+
PTC PTC Inc. Q3 2017 2017-07-19 C+
ABM ABM Industries Incorporated Q2 2017 2017-06-08 B
PPG PPG Industries, Inc. Q1 2017 2017-04-20 C
PDCO Patterson Companies, Inc. Q3 2017 2017-02-23 C
SXT Sensient Technologies Corporation Q4 2016 2017-02-10 A
BC Brunswick Corporation Q3 2016 2016-10-28 B+
SON Sonoco Products Company Q4 2015 2016-02-11 B

How the model reasoned

HOLX · Q4 2017 → YESThe question is: Does management identify a specific, named dimension on which the company currently underperforms — relative to industry peers, industry norms, or the company's own demonstrated poten...YES The transcript shows management explicitly diagnosing Cynosure’s commercial organization as the specific underperforming dimension (salesforce turnover, recruiting, and productivity lagging behind the company’s international business and its own best operations). They then describe concrete, already-executing actions—stopping voluntary turnover, rehiring high performers, instituting 90-day reviews, new compensation, and building “Cynosure 2.0”—as the mechanism to close the gap.
STKL · Q2 2017 → YESThe question is: Does management identify a specific, named dimension on which the company currently underperforms — relative to industry peers, industry norms, or the company's own demonstrated poten...YES The transcript shows management identifying a specific named gap in the bars segment, where operational issues at a particular facility are causing inefficient production and gross margin losses. They describe a rapid recovery team already executing systematic identification and correction of these issues, treating the gap as closable through their own operational efforts rather than external market improvements — this aligns with the criteria for a meaningful source of improvement.
ADNT · Q1 2018 → YESThe question is: Does management identify a specific, named dimension on which the company currently underperforms — relative to industry peers, industry norms, or the company's own demonstrated poten...YES The transcript shows management explicitly naming the Seat Structures and Mechanisms (SS&M) business as the specific underperforming dimension. They state it is “destroyed shareholder value” when run as currently organized, and that it is “impacting our financial results” with “significant impact.

More from the question bank

Paid to expand: the company's growth spendinThe product is disappearing into reorder rhyRecently unlocked doorWorking for customers it could not have servVolume records through a still-fixed gateTwo-sided intensityAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.